CMR Surgical

CMR Surgical expands into the Middle East

Retrieved on: 
Monday, December 20, 2021
Hospital, Company, Medtech, Ecosystem, List of free-trade zones in Dubai, Growth, Â, MAS, CMR Surgical, Adoption, General officer, Urology, Robotics, Patient, GMT, CMR, Surgeon, United Arab Emirates, Saudi German Hospitals, Region, Partnership, Oncology, Gynaecology

To support the region, CMR has invested in the opening of a Middle East hub office in UAE and expects further sales in the region in the short-term.

Key Points: 
  • To support the region, CMR has invested in the opening of a Middle East hub office in UAE and expects further sales in the region in the short-term.
  • The UAE, amongst other countries across the Middle East, has made considerable and rapid advances to adopt surgical robotics into clinical practice, and is seeing significant benefits by enabling more patients to receive MAS.
  • Per Vegard Nerseth, Chief Executive Officer of CMR Surgical said: It is wonderful to announce our commercial progress in the Middle East and we are excited to be amongst an ecosystem of innovative companies in Dubai.
  • Working with partners, CMR anticipates significant growth in the Middle East region in the coming years.

Versius surgical robot used for first time in an Italian public hospital

Retrieved on: 
Monday, December 13, 2021
Operation United Assistance, Hospital, Health, Cholecystectomy, IRCCS, Public health, Lung cancer, Culture, CMR Surgical, General surgery, Risk, Patient, Cardiothoracic surgery, GMT, Infection, Surgeon, CMR, Patient safety, Lung transplantation, Elective surgery, Urology, Medical device, Dentistry, Policlinico San Matteo

CMR Surgical (CMR) a global surgical robotics business today announced the introduction of the Versius Surgical Robotic System, at Policlinico di Milano, a leading research hospital and care institute (IRCCS), and one of the largest healthcare facilities in Lombardy, Italy.

Key Points: 
  • CMR Surgical (CMR) a global surgical robotics business today announced the introduction of the Versius Surgical Robotic System, at Policlinico di Milano, a leading research hospital and care institute (IRCCS), and one of the largest healthcare facilities in Lombardy, Italy.
  • Within the hospital, Versius will be used in a multi-specialty robotics programme including thoracic and general surgery.
  • The Italian surgical robotics market is one of the most significant in Europe with cutting-edge technologies being increasingly adopted.
  • The installation of the Versius robot and in general the implementation of these advanced medical tools represents a major step forward for public health.

Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise Lombardo

Retrieved on: 
Tuesday, November 9, 2021
Seizure, Safety, University, Tourette syndrome, Industry, Therapy, TSC, Tuberous sclerosis complex tumor suppressors, Director, MD, Clinical trial, CEO, Knowledge, MBA, CMR Surgical, Sofinnova, CNS, Board, Chair, PDE10A, Brown University, Company, GLOBE, Solution, Axovant Sciences, Kriyā, Board of directors, Nervous system, Ironwood Pharmaceuticals, Glutamate (neurotransmitter), Central nervous system, Trigeminal neuralgia, Patient, Yale University, Brain, Pharmaceutical industry, Management

"I am very pleased to welcome Catherine and Ilise to the board of Noema Pharma.

Key Points: 
  • "I am very pleased to welcome Catherine and Ilise to the board of Noema Pharma.
  • The two new appointments further expand the Company's board and follow the recent appointment of Jeffrey Jonas MD as the Chairman of the Board of Directors.
  • "I am delighted to be joining Noema Pharma's board and I'm looking forward to working with Noemas dedicated and talented executive team," said Ilise Lombardo MD, Board Member of Noema Pharma.
  • Catherine Moukheibir currently serves on the Board of Directors at DNA Script, Asceneuron, Biotalys, CMR Surgical, Ironwood Pharmaceuticals and Orphazyme.

CMR global footprint grows with regulatory approval for Versius in Brazil

Retrieved on: 
Tuesday, November 9, 2021
Health, Operation, Technology, Growth, CMR Surgical, GMT, Paola Lattus, Hospital, CMR, Physician, Patient, Surgeon, Medical device

CMRSurgical (CMR) a global surgical robotics business announced that it has received regulatory approval for the Versius Surgical Robotic System from the BrazilianHealth Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.

Key Points: 
  • CMRSurgical (CMR) a global surgical robotics business announced that it has received regulatory approval for the Versius Surgical Robotic System from the BrazilianHealth Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.
  • Brazil is a strategically important market for CMR, where robotic assisted surgery is considered a key innovation for surgical practice.
  • With the approval, CMR is set to further expand its global presence, offering innovative surgical robotic technology in Brazil and more widely across Latin America where other countries are typically influenced by regulatory developments in Brazil.
  • Versius is already used by surgeons worldwide in different surgical specialties and we anticipate strong demand for Versius in Brazil.

CMR global footprint grows with regulatory approval for Versius in Brazil

Retrieved on: 
Tuesday, November 9, 2021
Health, Operation, Technology, Growth, CMR Surgical, GMT, Paola Lattus, Hospital, CMR, Physician, Patient, Surgeon, Medical device

CMRSurgical (CMR) a global surgical robotics business announced that it has received regulatory approval for the Versius Surgical Robotic System from the BrazilianHealth Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.

Key Points: 
  • CMRSurgical (CMR) a global surgical robotics business announced that it has received regulatory approval for the Versius Surgical Robotic System from the BrazilianHealth Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.
  • Brazil is a strategically important market for CMR, where robotic assisted surgery is considered a key innovation for surgical practice.
  • With the approval, CMR is set to further expand its global presence, offering innovative surgical robotic technology in Brazil and more widely across Latin America where other countries are typically influenced by regulatory developments in Brazil.
  • Versius is already used by surgeons worldwide in different surgical specialties and we anticipate strong demand for Versius in Brazil.

CMR global footprint grows with regulatory approval for Versius in Brazil

Retrieved on: 
Tuesday, November 9, 2021
Health, Operation, Technology, Growth, CMR Surgical, GMT, Paola Lattus, Hospital, CMR, Physician, Patient, Surgeon, Medical device

CMRSurgical (CMR) a global surgical robotics business announced that it has received regulatory approval for the Versius Surgical Robotic System from the BrazilianHealth Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.

Key Points: 
  • CMRSurgical (CMR) a global surgical robotics business announced that it has received regulatory approval for the Versius Surgical Robotic System from the BrazilianHealth Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.
  • Brazil is a strategically important market for CMR, where robotic assisted surgery is considered a key innovation for surgical practice.
  • With the approval, CMR is set to further expand its global presence, offering innovative surgical robotic technology in Brazil and more widely across Latin America where other countries are typically influenced by regulatory developments in Brazil.
  • Versius is already used by surgeons worldwide in different surgical specialties and we anticipate strong demand for Versius in Brazil.

DNA Script Appoints Don Kania as Chairman of the Board of Directors, Catherine Moukheibir as Audit Chair and Bonnie Anderson as Independent Director

Retrieved on: 
Thursday, October 21, 2021
Research, Technology, Medical Devices, FDA, Genetics, Clinical Trials, Biotechnology, Hardware, Health, Science, SYNTAX, Enzyme, Research, Technology, Industry, Genomics, Partnership, EDS, CMR Surgical, View, Director, Leadership, Synthetic biology, Board on Science, Technology, and Economic Policy, Board, CEO, Organic acid, FEI Company, Script, Thermo Fisher Scientific, DNA, Management

DNA Script, a leader in Enzymatic DNA Synthesis (EDS), today announced the appointment of Don Kania, Ph.D. as Chairman of the Board of Directors, Catherine Moukheibir as Audit Chair and Bonnie Anderson as independent new members of the Board.

Key Points: 
  • DNA Script, a leader in Enzymatic DNA Synthesis (EDS), today announced the appointment of Don Kania, Ph.D. as Chairman of the Board of Directors, Catherine Moukheibir as Audit Chair and Bonnie Anderson as independent new members of the Board.
  • The life sciences industry is in the process of revolutionizing our world, starting with healthcare and expanding into other markets.
  • Moukheibir brings over 30 years of leadership experience in finance, capital markets and life sciences to DNA Script.
  • DNA Script is at a pivotal point with the targeted commercial launch of our SYNTAX Platform, said Thomas Ybert, DNA Script co-founder and CEO.

CMR Surgical to build new global manufacturing facility to meet Versius demand

Retrieved on: 
Monday, October 11, 2021
Workforce, R, Surgeon, CMR Surgical, Hospital, GMT, CMR, Technology, Medical device

CMRSurgical (CMR) a global surgical robotics business today announcedplans to opena new large-scale manufacturing facility in Cambridgeshire, UK.The site will enable upscaled manufacturing processesto meet theincreasing globaldemand for the Versius Surgical Robotic System,now established as a valuable surgical tool ina number ofhospitals across Europe, India, Australia and the Middle East.

Key Points: 
  • CMRSurgical (CMR) a global surgical robotics business today announcedplans to opena new large-scale manufacturing facility in Cambridgeshire, UK.The site will enable upscaled manufacturing processesto meet theincreasing globaldemand for the Versius Surgical Robotic System,now established as a valuable surgical tool ina number ofhospitals across Europe, India, Australia and the Middle East.
  • Alongside this, CMR is committed to investing in future technology developments for Versius and its digital ecosystem that will benefit surgeons and improve surgical care on a global scale.
  • Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, commented: We continue to see strong demand for Versius in markets around the world and our commitment to building a new manufacturing facility reflects this whilst highlighting the scale of our ambition to transform surgery.
  • Barrington DArcy, Chief Operations Officer of CMR Surgical, said: Establishing a world-class manufacturing facility to meet worldwide demand was a logical step forward for CMR.

CMR Surgical to build new global manufacturing facility to meet Versius demand

Retrieved on: 
Monday, October 11, 2021
Workforce, R, Surgeon, CMR Surgical, Hospital, GMT, CMR, Technology, Medical device

CMRSurgical (CMR) a global surgical robotics business today announcedplans to opena new large-scale manufacturing facility in Cambridgeshire, UK.The site will enable upscaled manufacturing processesto meet theincreasing globaldemand for the Versius Surgical Robotic System,now established as a valuable surgical tool ina number ofhospitals across Europe, India, Australia and the Middle East.

Key Points: 
  • CMRSurgical (CMR) a global surgical robotics business today announcedplans to opena new large-scale manufacturing facility in Cambridgeshire, UK.The site will enable upscaled manufacturing processesto meet theincreasing globaldemand for the Versius Surgical Robotic System,now established as a valuable surgical tool ina number ofhospitals across Europe, India, Australia and the Middle East.
  • Alongside this, CMR is committed to investing in future technology developments for Versius and its digital ecosystem that will benefit surgeons and improve surgical care on a global scale.
  • Per Vegard Nerseth, Chief Executive Officer of CMR Surgical, commented: We continue to see strong demand for Versius in markets around the world and our commitment to building a new manufacturing facility reflects this whilst highlighting the scale of our ambition to transform surgery.
  • Barrington DArcy, Chief Operations Officer of CMR Surgical, said: Establishing a world-class manufacturing facility to meet worldwide demand was a logical step forward for CMR.

Nuvo Group Recruits New CEO to Lead Next Stage of Company Growth

Retrieved on: 
Monday, August 9, 2021
Technology, TEL, CMR Surgical, Teladoc Health, GE, Health, Hospital, FDA, CEO, Lumicel Animation Studios, Procter, Procter & Gamble, University, Contraindication, INVU, Growth, Multimedia, Parent, Data collection, Jefferson Health, AI, Woman, Management

"Kelly is a seasoned healthcare leader with a track record of commercialization success, which I believe is instrumental as we enter Nuvo's next stage of growth," said Oz.

Key Points: 
  • "Kelly is a seasoned healthcare leader with a track record of commercialization success, which I believe is instrumental as we enter Nuvo's next stage of growth," said Oz.
  • "At Nuvo, we are committed to bringing together the best of health care with the best of health tech," said Henretta.
  • Londy currently serves on the board of directors for CMR Surgical, a company developing and bringing to market a next-generation surgical robot.
  • Nuvo Group is committed to serving providers and expectant mothers by advancing pregnancy care with new technology, tools, and practices.